Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci | Zendy

Benjamin R. Knoll | Zendy; Imad M. Tleyjeh | Zendy; James M. Steckelberg | Zendy; Walter R. Wilson | Zendy; Larry M. Baddour | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci

Author(s) -

Benjamin R. Knoll,

Imad M. Tleyjeh,

James M. Steckelberg,

Walter R. Wilson,

Larry M. Baddour

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/518174

Subject(s) - medicine , infective endocarditis , penicillin , viridans streptococci , ceftriaxone , regimen , endocarditis , antibiotics , surgery , population , streptococcus , microbiology and biotechnology , genetics , environmental health , bacteria , biology

The emergence of viridans group streptococci that are relatively or fully resistant to penicillin is increasingly being recognized worldwide, but only a scant number of penicillin-resistant isolates have been described as a cause of infective endocarditis. Because of the paucity of data, it has been difficult to define optimal treatment regimens for this syndrome. Thus, recommendations for therapy have largely been made on the basis of consensus opinion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research